Comment from Anonymous
AnonymousOpposeIndividual
Summary: Adele Kootz expresses strong opposition to the proposed action, arguing that the FDA should not weaken safety protocols or remove Risk Evaluation and Mitigation Strategy (REMs) requirements for mifepristone. She cites concerns regarding the drug's safety, potential for abuse, and its impact on women's health, urging the FDA to maintain and strengthen current regulations.
To whom it may concern,
The abortion pill is causing women to have PTSD as now they have abortions in their very own bathrooms bleeding all over the place and finding their baby dead in the toilet. The battle on women continues. How this protocol became legal in the first place is a disgrace. Not only will women have PTSD, now men who don’t want to parent can give a woman these pills without her knowing. The abortion pill IN NO WAY helps women. It helps men to escape responsibility even more than surgical abortion.
I am strongly opposed to the FDA weakening safety protocols and removing the Risk Evaluation and Mitigation Strategy (REMs) safety requirements for the abortion drug mifepristone. Drugs with significant risks must be strictly regulated, and mifepristone is no exception. FDA data links this drug to at least 36 deaths and thousands of adverse events. A 2024 Ethics and Public Policy Center report found that 11% of chemical abortions resulted in adverse events.
When a drug poses such dangers to women’s health and lives, robust safety measures are essential. I urge the FDA to maintain—and strengthen—current safety protocols for mifepristone to protect women nationwide.
Signed, Adele Kootz